Example: Heart Attack
Search clinical trials for: Sodium thiosulfate
Total 53 results
-
NCT03150420TerminatedConditions: Calciphylaxis
-
NCT02538939CompletedConditions: Calcific Tendinitis of the Rotator Cuff
-
NCT03017963CompletedConditions: Acute Coronary Syndrome
-
NCT04251832RecruitingConditions: Sodium Thiosulfate; Calcific Tendinitis; Shoulder Pain
-
NCT03639779TerminatedConditions: Calcinosis Cutis
-
NCT01008631CompletedConditions: Renal Failure
-
NCT01918904WithdrawnConditions: Calcinosis Cutis
-
NCT03267277RecruitingConditions: Dermatomyositis; Idiopathic Inflammatory Myopathies
-
NCT00568399CompletedConditions: Complication of Hemodialysis; Cardiovascular Diseases
-
NCT00716976CompletedConditions: Brain Tumor; Central Nervous System Tumor; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Liver Cancer; Neuroblastoma; Ototoxicity; Ovarian Cancer; Sarcoma
-
NCT02624479Unknown statusConditions: Healthy
-
NCT02527213TerminatedConditions: Calciphylaxis; Calcific Uremic Arteriolopathy
-
NCT01088555CompletedConditions: Kidney Stones
-
NCT02281006TerminatedConditions: DDP; Head and Neck Cancer; Adverse Effect
-
NCT01572844CompletedConditions: Calcinosis
-
NCT04292184Enrolling by invitationConditions: End Stage Renal Disease (ESRD)
-
NCT02899364RecruitingConditions: Myocardial Infarction; Heart Failure
-
NCT04132882AvailableConditions: Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma
-
NCT00720772CompletedConditions: Coronary Calcification; Vascular Calcification
-
NCT01369641TerminatedConditions: Cancer
-
NCT00165503TerminatedConditions: Pleural Mesothelioma; Malignant Pleural Mesothelioma
-
NCT00652132CompletedConditions: Liver Cancer; Ototoxicity
-
NCT00165516CompletedConditions: Pleural Mesothelioma; Malignant Pleural Mesothelioma
-
NCT03146793Unknown statusConditions: Calciphylaxis; Renal Insufficiency, Chronic
-
NCT04541355RecruitingConditions: Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Locally Advanced Head and Neck Squamous Cell Carcinoma; Locally Advanced Hypopharyngeal Squamous Cell Carcinoma; Locally Advanced Laryngeal Squamous Cell Carcinoma; Locally Advanced Oral Cavity Squamous Cell Carcinoma; Locally Advanced Oropharyngeal Squamous Cell Carcinoma; Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Stage III Hypopharyngeal Carcinoma AJCC v8; Stage III Laryngeal Cancer AJCC v8; Stage III Lip and Oral Cavity Cancer AJCC v8; Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IV Hypopharyngeal Carcinoma AJCC v8; Stage IV Laryngeal Cancer AJCC v8; Stage IV Lip and Oral Cavity Cancer AJCC v8; Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVA Hypopharyngeal Carcinoma AJCC v8; Stage IVA Laryngeal Cancer AJCC v8; Stage IVA Lip and Oral Cavity Cancer AJCC v8; Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVB Hypopharyngeal Carcinoma AJCC v8; Stage IVB Laryngeal Cancer AJCC v8; Stage IVB Lip and Oral Cavity Cancer AJCC v8; Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVC Hypopharyngeal Carcinoma AJCC v8; Stage IVC Laryngeal Cancer AJCC v8; Stage IVC Lip and Oral Cavity Cancer AJCC v8; Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8